Dangerous Drug: Morphine Sulfate



Dangerous Drug: Morphine Sulfate





(mor’ feen)

Timed-release: AvinzaDNC, KadianDNC, MS ContinDNC, Oramorph SRDNC, ratio-Morphine SR (CAN)DNC

Oral solution: MSIR, Roxanol, Roxanol T

Rectal suppositories: RMS

Injection: Astramorph PF, Duramorph, Morphine HP Injection (CAN), MOS Sulfate (CAN), PMS Morphine (CAN)

Preservative-free concentrate for microinfusion devices for intraspinal use: Infumorph, Morphine LP Injection (CAN), Morphine LP Epidural (CAN)

Liposome injection: DepoDur

PREGNANCY CATEGORY C

CONTROLLED SUBSTANCE C-II


Drug class

Opioid agonist analgesic


Therapeutic Actions

Principal opium alkaloid; acts as agonist at specific opioid receptors in the CNS to produce analgesia, euphoria, sedation; the receptors mediating these effects are thought to be the same as those mediating the effects of endogenous opioids (enkephalins, endorphins).


Indications



  • Relief of moderate to severe acute and chronic pain


  • Preoperative medication to sedate and allay apprehension, facilitate induction of anesthesia, and reduce anesthetic dosage


  • Analgesic adjunct during anesthesia


  • Component of most preparations that are oral alcoholic solutions used for chronic severe pain, especially in terminal cancer patients


  • Intraspinal use with microinfusion devices for the relief of intractable pain


  • Treatment of pain following major surgery, ER liposome injection for single-dose administration by epidural route at the lumbar level


  • Unlabeled uses: Relief of pain associated with MI, postherpetic neuralgia, agitation, angina, pulmonary edema



Available Forms

Injection—0.5, 1, 2, 4, 5, 8, 10, 15, 25, 50 mg/mL; tablets—15, 30 mg; CR tabletsDNC—15, 30, 60, 100, 200 mg; ER tabletsDNC—15, 30, 60, 100, 200 mg; soluble tablets—10, 15, 30 mg; oral solution—20 mg/mL; 10, 20, 100 mg/5 mL; concentrated oral solution—20 mg/mL, 100 mg/5 mL; suppositories—5, 10, 20, 30 mg; SR capsulesDNC—20, 30, 50, 60, 100 mg; ER capsulesDNC—30, 45, 60, 75, 90, 120 mg (Avinza); 10, 20, 30, 40, 50, 60, 70, 80, 100, 130, 150, 200 mg (Kadian); liposome injection—10 mg/mL


Dosages

Adults

Oral

One-third to one-sixth as effective as parenteral administration because of first-pass metabolism; 5–30 mg every 4 hr PO. CR, ER, and SR: 30 mg every 8–12 hr PO or as directed by physician; Kadian: 20–100 mg PO daily–24-hr release system; MS Contin: 200 mg PO every 12 hr; Avinza: 30 mg PO daily; if opioid naïve, increase by 30 mg (or lower) increments every 4 days.

IM or subcutaneous

10 mg (range, 5–20 mg) IM or subcutaneously every 4 hr or as directed by physician.


IV

10 mg IV every 4 hr. Usual individual range is 5–15 mg; usual daily dose is 12–120 mg.

Rectal

10–20 mg rectally every 4 hr or as directed by physician.

Epidural

Initial injection of 5 mg in the lumbar region may provide pain relief for up to 24 hr. If adequate pain relief is not achieved within 1 hr, incremental doses of 1–2 mg may be given at intervals sufficient to assess effectiveness, up to 10 mg/24 hr. For continuous infusion, initial dose of 2–4 mg/24 hr is recommended. Further doses of 1–2 mg may be given if pain relief is not achieved initially.

Liposome injection

10–15 mg by lumbar epidural injection using a catheter or needle prior to major surgery or after clamping the umbilical cord during cesarean section.

Only gold members can continue reading. Log In or Register to continue

Stay updated, free articles. Join our Telegram channel

Jul 21, 2016 | Posted by in NURSING | Comments Off on Dangerous Drug: Morphine Sulfate

Full access? Get Clinical Tree

Get Clinical Tree app for offline access